Clinical Guides
Pre-eclampsia: Prevention, Recognition, Stabilisation and Birth Planning
An India-contextualised, clinician-facing educational guide to pre-eclampsia; urgent treatment, transfer and delivery decisions must follow the current local obstetric emergency protocol and senior supervision.
MedNext Academy | 13 min read
Pre-eclampsia: Prevention, Recognition, Stabilisation and Birth Planning
An India-contextualised, clinician-facing educational guide to pre-eclampsia; urgent treatment, transfer and delivery decisions must follow the current local obstetric emergency protocol and senior supervision.
Summary
Pre-eclampsia is a multisystem pregnancy disorder, usually arising after 20 weeks, in which new hypertension is accompanied by proteinuria and/or maternal organ dysfunction or uteroplacental dysfunction. It can occur without proteinuria and may first present intrapartum or postpartum. Severe disease can progress to eclampsia, stroke, pulmonary oedema, acute kidney injury, liver injury, thrombocytopenia, placental abruption, fetal growth restriction, preterm birth and stillbirth. The clinical task is not to wait for a classic triad; it is to detect deterioration early, treat dangerous blood pressure promptly and plan birth when maternal or fetal risk makes continuing pregnancy unsafe.
Measure blood pressure with validated equipment, correct cuff size and a documented technique. Hypertension is generally a systolic blood pressure of 140 mmHg or more or diastolic pressure of 90 mmHg or more; severe hypertension is 160 mmHg systolic or 110 mmHg diastolic or more. A severe reading needs urgent assessment and should not be delayed by a 4-hour confirmation interval when treatment is required. Ask at every relevant encounter about headache, visual symptoms, severe epigastric or right-upper-quadrant pain, nausea or vomiting, breathlessness, chest pain, reduced urine output and reduced fetal movements.
Management requires maternal and fetal assessment together. Stabilise airway, breathing and circulation in an emergency; summon obstetric, anaesthetic and neonatal support; obtain focused blood and urine tests; assess the fetus; and decide level of care and transfer. Delivery is definitive treatment for the placental disease, but a delivery date is never chosen from gestation alone. The plan must be revised when symptoms, laboratory values, blood pressure, fetal growth or fetal testing changes. Postpartum surveillance is essential because disease can begin or worsen after birth.
How Common Is It?
Pre-eclampsia affects an important minority of pregnancies worldwide; ACOG cites a global range of 2% to 8%, but that range must not be presented as an Indian prevalence estimate. Local burden varies with baseline hypertension, diabetes, obesity, access to antenatal care, referral mix, diagnostic definitions and whether postpartum cases are captured. The operational implication is universal: every antenatal and postnatal service needs a reliable pathway for blood-pressure measurement, warning-symptom education, basic evaluation, emergency treatment and transfer.
Its impact is greater than a number on an antenatal chart. Maternal harm may arise from cerebral haemorrhage, seizure, HELLP syndrome, renal injury, liver complications, pulmonary oedema and coagulopathy. Placental dysfunction can cause fetal growth restriction, abnormal Doppler findings, preterm birth, hypoxia, placental abruption and stillbirth. A person who initially appears stable can deteriorate over hours; conversely, a single abnormal observation should prompt reassessment rather than a fixed diagnosis or automatic delivery.
In India, the relevant systems question is whether the person can receive serial observations, laboratory testing, fetal surveillance, blood products, critical care, timely operative birth and neonatal support if necessary. These capabilities may be separated by long transfer distances. Never use a low-risk booking profile, absence of oedema or a normal earlier urine test to reassure someone with current severe symptoms or severe hypertension. Public-health prevention matters, but emergency readiness and a clear postnatal handover are equally important.
Risk Factors
Risk factors guide prevention and intensity of surveillance; they do not predict every case. High-risk factors used by current guidelines include hypertensive disease in a previous pregnancy, chronic kidney disease, autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome, type 1 or type 2 diabetes, and chronic hypertension. Moderate factors include nulliparity, age 40 years or older, pregnancy interval above 10 years, BMI of 35 kg/m2 or more at first visit, family history of pre-eclampsia and multifetal pregnancy. ACOG additionally treats multifetal gestation as high risk and includes in-vitro conception among moderate factors. Apply a locally approved risk tool rather than combining international lists into an unverified score.
At booking, record exact details of any previous hypertensive disorder: onset, seizure, preterm birth, fetal growth restriction, stillbirth, abruption, ICU admission, postpartum hypertension and medicines. Establish pre-pregnancy or early-pregnancy blood pressure, renal disease, diabetes complications, autoimmune disease, thrombosis history, current medicines and use of aspirin or anticoagulants. Ask about accessibility of return visits, validated home monitoring, transport and the closest facility able to manage a maternal emergency and preterm newborn.
Risk assessment is repeated, not completed at booking. New headache, visual disturbance, upper abdominal pain, breathlessness, sudden clinical deterioration, reduced fetal movements or a rising blood-pressure pattern override a reassuring earlier risk assessment. Explain risk without blame, especially around weight, age, fertility treatment or a previous adverse pregnancy outcome. The goal is timely prevention and surveillance, not anxiety or a promise that aspirin eliminates risk.
Diagnosis
History
Confirm gestation, baseline pressure, previous readings and their timing, symptoms, fetal movement, vaginal bleeding, contractions, fluid loss, medicines and adherence. Ask about severe headache, visual scotomata, epigastric or right-upper-quadrant pain, nausea, vomiting, dyspnoea, chest pain, confusion, seizure and urine output. Clarify chronic hypertension, kidney disease, diabetes, autoimmune disease, multiple gestation and prior pre-eclampsia. A symptom history is not a substitute for observation; a patient with no headache may still have severe disease.
Examination
Repeat blood pressure using an appropriate cuff and documented position, assess pulse, respiratory rate, oxygen saturation, temperature, mental status, lung crackles, reflexes where magnesium toxicity or neurology is relevant, peripheral perfusion and fluid balance. Assess abdominal tenderness, uterine activity, presentation and fetal heart according to capability. Look for pulmonary oedema, abruption, neurological deficit or another acute diagnosis. Oedema may support concern in context but is not diagnostic.
Investigations
Evaluate proteinuria using the current local method; Current guidelines recommends automated reagent-strip testing initially and quantification by protein:creatinine or albumin:creatinine ratio if positive, rather than routine 24-hour collection. Obtain full blood count with platelets, renal function, liver transaminases and other tests guided by severity. Consider haemolysis and coagulation studies where HELLP, abruption, bleeding or critical illness is suspected. Fetal assessment can include cardiotocography when clinically indicated, ultrasound growth and amniotic fluid assessment, and umbilical artery Doppler according to gestation and local protocol. Do not use one normal test to exclude pre-eclampsia when symptoms, severe hypertension or maternal-fetal deterioration is present.
Differential Diagnosis
Classify chronic hypertension, gestational hypertension, pre-eclampsia, superimposed pre-eclampsia and eclampsia because monitoring and delivery planning differ. Chronic hypertension is present at booking, before 20 weeks or when antihypertensive treatment predates referral. Gestational hypertension is new hypertension after 20 weeks without current pre-eclampsia features. In someone with chronic hypertension, a new proteinuria pattern, maternal organ dysfunction or uteroplacental dysfunction can indicate superimposed disease.
Headache, visual symptoms, epigastric pain, abnormal liver tests, thrombocytopenia or renal impairment also require consideration of migraine, cerebral venous thrombosis, intracranial haemorrhage, stroke, hepatitis, cholecystitis, acute fatty liver of pregnancy, thrombotic thrombocytopenic purpura, haemolysis, sepsis, lupus flare and primary renal disease. Pulmonary oedema can reflect cardiac disease, fluid overload, pulmonary embolism or infection. A seizure may be eclampsia but epilepsy, metabolic disturbance, meningitis, intracranial pathology, intoxication and trauma must be considered when the presentation is atypical.
Proteinuria may result from urinary infection, chronic kidney disease or specimen contamination; it does not independently settle the diagnosis. Fetal growth restriction has placental and non-placental causes. Use senior obstetric, medical, anaesthetic, critical-care and neonatal input when classification is uncertain. Never delay treatment of severe hypertension or seizure while completing a broad differential.
Management
Decide the setting after maternal and fetal assessment. Severe hypertension, severe symptoms, eclampsia, pulmonary oedema, abnormal neurology, worsening blood tests, fetal compromise or concern about safe follow-up requires admission and senior obstetric-led management. Establish intravenous access when required, obtain blood for urgent studies, chart observations and fluid balance, group and save blood as indicated, and contact anaesthesia, critical care and neonatology early. If a lower-level facility cannot provide ongoing surveillance or urgent birth, stabilise within competence and transfer with documented observations, treatments and a direct receiving-team handover.
For hypertension in pregnancy, current guidelines recommends starting treatment at sustained 140/90 mmHg and aiming for 135/85 mmHg. It recommends labetalol first, nifedipine if labetalol is unsuitable, and methyldopa if both are unsuitable, based on prior therapy, adverse effects, fetal considerations and preference. Acute severe hypertension needs immediate protocolised treatment in a monitored setting; choose the agent, route and repeat interval from the local obstetric emergency chart rather than improvising oral treatment. ACE inhibitors and angiotensin-receptor blockers require urgent pregnancy medication review.
Birth planning is continuously reassessed. Current guidelines recommends initiating birth within 24 to 48 hours from 37 weeks onward in pre-eclampsia. Before 34 weeks, continue surveillance unless maternal or fetal thresholds for planned early birth are met; from 34 weeks to 36 weeks plus 6 days, balance maternal and fetal indications, neonatal support, corticosteroid need and the person's preference. Do not convert these timing recommendations into a home decision or delay birth when there is refractory severe hypertension, eclampsia, pulmonary oedema, worsening laboratory results, placental abruption or non-reassuring fetal status.
Monitor symptoms, blood pressure, urine output, platelets, renal and liver function and fetal status at a frequency set by severity. Avoid reflex intravenous fluid loading: pre-eclampsia predisposes to pulmonary oedema, and international guidelines specifically advises against routine preloading before regional analgesia in severe disease. Give fluid for a clear indication with an intake-output plan and senior review. Postpartum, current guidelines advises BP measurement at least four times daily while inpatient, at least once between days 3 and 5, and on alternate days thereafter if no antihypertensive was used; people treated with antihypertensives need at least four inpatient measurements daily and then checks every 1 to 2 days for up to two weeks after transfer. Antenatal corticosteroids, magnesium sulfate, venous thromboprophylaxis and neonatal planning are gestation- and risk-specific interventions, not automatic additions to every case.
Prescribing Information
Aspirin prevents some cases; it does not treat established pre-eclampsia. Current guidelines advises 75 to 150 mg daily from 12 weeks until birth for one high-risk factor or more than one moderate-risk factor. ACOG/SMFM recommends 81 mg daily for high-risk patients, initiated between 12 and 28 weeks, optimally before 16 weeks, and continued until delivery. These are jurisdiction-specific recommendations. In India, confirm the current facility protocol, product, contraindications, bleeding history and obstetric plan before prescribing; do not advise a patient to self-start pharmacy aspirin. Do not use salt restriction, bed rest, diuretics, heparin or nutritional supplements solely to prevent pre-eclampsia without a separate indication.
For severe pre-eclampsia or eclampsia, magnesium sulfate is an emergency drug given where airway, respiratory rate, reflexes, urine output and calcium rescue are available. Current guidelines specifies an intravenous 4 g loading dose over 5 minutes followed by 1 g per hour for 24 hours, with an additional 2 to 4 g IV over 5 minutes for recurrent seizures. NHM CEmONC materials use protocolled magnesium regimens and require toxicity checks; follow the exact local regimen rather than mixing schedules. Withhold further magnesium and obtain senior help for absent reflexes, respiratory depression or oliguria. Calcium gluconate is the local protocol antidote for severe toxicity.
Do not give a universal outpatient dose table for labetalol, nifedipine, hydralazine or methyldopa in this guide: emergency route, titration, contraindications, fetal monitoring and cumulative limits depend on the current protocol. Record drug, formulation, dose, route, time, BP response and adverse effects. Avoid NSAIDs, over-the-counter products and herbal remedies only where clinical context or local policy indicates; medication reconciliation and breastfeeding-compatible postnatal planning require an individual review.
When to Refer
Refer immediately to an obstetric emergency unit for severe hypertension, seizure, altered consciousness, severe headache, visual disturbance, epigastric or right-upper-quadrant pain, oxygen requirement, pulmonary crackles, chest pain, reduced urine output, suspected HELLP syndrome, abruption, heavy bleeding or reduced fetal movements. Do not wait for proteinuria, a scan appointment or repeat routine laboratory results. Call for emergency help, protect the airway and prevent injury during a seizure; do not put anything in the mouth.
Refer urgently to obstetric-led care for new hypertension after 20 weeks, chronic hypertension with a changing pattern, possible superimposed disease, proteinuria with hypertension, abnormal platelets, creatinine or transaminases, persistent symptoms, fetal growth concern or uncertainty over safe outpatient surveillance. Transfer early to a facility with maternal critical care, blood products, anaesthesia and neonatal intensive care when early birth may be needed. Time and transport are clinical variables; a stable patient in a remote setting may need a lower threshold for transfer.
Ask for medical, renal, haematology, cardiology, critical-care or neurology support for resistant hypertension, pulmonary oedema, kidney injury, significant thrombocytopenia, atypical seizures or difficult differential diagnosis. After discharge, hand over the blood-pressure plan, drugs, laboratory trajectory, danger symptoms, postnatal checks and future-pregnancy counselling to the person and the receiving community or primary-care team. A verbal handover without gestation, measurements, treatments and escalation triggers is unsafe.
Red Flags
Emergency warning features include systolic pressure of 160 mmHg or more, diastolic pressure of 110 mmHg or more, severe or persistent headache, visual disturbance, epigastric or right-upper-quadrant pain, repeated vomiting, dyspnoea, chest pain, cyanosis, pulmonary crackles, confusion, seizure, focal neurology, oliguria, jaundice, heavy vaginal bleeding or suspected abruption. Rapidly falling platelets, rising creatinine, rising transaminases, haemolysis or worsening hypertension require senior reassessment even when the person feels well.
Reduced fetal movement, non-reassuring fetal monitoring, severe growth restriction, absent or reversed end-diastolic flow when Doppler is used, rupture of membranes, labour or vaginal bleeding all require same-day maternity assessment. Maternal resuscitation and treatment must not be delayed while a fetal test is obtained. Birth planning must include neonatal capability and maternal stability, not a single ultrasound measurement.
Postpartum pre-eclampsia is a safety-critical diagnosis. New headache, visual symptoms, upper-abdominal pain, dyspnoea, chest pain, seizure, confusion or high blood pressure after birth needs urgent assessment, including after discharge. Tell the person exactly where to seek help and who will check blood pressure. Normal ankle swelling, tiredness or anxiety should not be used to explain away a neurological or respiratory symptom. A person may first develop serious disease after an apparently uncomplicated delivery.
Indian Clinical Context
The National Health Mission revised CEmONC curriculum provides Indian emergency-training context for eclampsia, magnesium sulfate safety, blood-pressure control, fluid monitoring and referral. It does not replace a hospital’s current obstetric protocol, formulary, critical-care policy or specialist decision on timing of birth. international and ACOG are authoritative comparators, but their product strengths, aspirin dose, tests, staffing assumptions and delivery pathways must not be copied uncritically into India. The safe response is a current locally approved chart, senior support and a documented transfer plan.
Resource availability can differ sharply between an antenatal clinic, community health centre, district hospital and tertiary unit. Before managing a suspected case, establish whether serial BP measurement, urine protein testing, platelet count, renal and liver tests, ultrasound, fetal monitoring, magnesium sulfate, antihypertensives, oxygen, blood products, anaesthesia, caesarean capacity and neonatal support are actually available. When they are not, initial stabilisation and early transfer are safer than repeated observation without an escalation route. Never reassure a person with concerning symptoms simply because a facility cannot perform a test.
Explain warning symptoms in the person’s preferred language, ask about travel, cost, childcare and decision-makers, and give a written return plan where possible. Respect refusal or delay without abandoning care: explain the maternal and fetal risks, involve support people with consent and arrange the safest feasible route. This guide makes no claim about free medicines, ambulance response or state-specific referral networks. Verify local contacts and postpartum services at the point of care.
NMC Competency Mapping
The NMC Competency Based Medical Education Curriculum 2024 provides the Indian educational basis for recognising obstetric emergencies, safe prescribing, communication, escalation and referral. Pre-eclampsia integrates antenatal care, blood-pressure technique, renal and liver physiology, maternal resuscitation, fetal assessment, pharmacology, anaesthesia, critical care and postnatal continuity. This guide does not assign an invented condition-specific competency code; institutions should use the currently approved obstetrics competency ledger.
At Know level, learners should classify chronic hypertension, gestational hypertension, pre-eclampsia, superimposed pre-eclampsia and eclampsia; explain why proteinuria alone is insufficient; list maternal and fetal complications; and describe risk-based aspirin prevention. They should understand that delivery is definitive treatment but that its timing is a specialist balance of prematurity and deterioration.
At Know How level, learners should measure blood pressure correctly, recognise severe hypertension and danger symptoms, request appropriate urine, blood and fetal assessment, identify an eclamptic emergency, and formulate a referral. They should know that magnesium sulfate and antihypertensive regimens require protocol-specific monitoring and that excessive fluid can be harmful.
At Show How level, under supervision, learners should communicate urgency without panic, protect dignity, document exact values and times, activate local emergency help, maintain a fluid and drug record, prepare a transfer handover and ensure postpartum safety-netting. Assessment should reward early recognition and safe escalation, not unsupported recall of an isolated medicine dose.
Key Exam Pearls for NEET PG
Pre-eclampsia is new hypertension after 20 weeks with proteinuria and/or maternal organ dysfunction or uteroplacental dysfunction; it can occur without proteinuria and postpartum. Severe hypertension is 160/110 mmHg or more and requires urgent treatment rather than delayed confirmation. Oedema is neither necessary nor sufficient for diagnosis.
Risk-based aspirin prevention is started early in pregnancy for eligible patients, but international doses differ: current guidelines 75 to 150 mg from 12 weeks until birth, and ACOG/SMFM 81 mg from 12 to 28 weeks, optimally before 16 weeks, until delivery. State the guideline and local protocol; do not invent a universal Indian dose.
current guidelines aims to treat sustained pregnancy hypertension from 140/90 mmHg with a target of 135/85 mmHg and considers labetalol, nifedipine then methyldopa according to suitability. Severe disease needs maternal stabilisation, serial laboratory and fetal assessment, magnesium sulfate when indicated, careful fluids and planned birth.
Magnesium sulfate treats and prevents eclamptic seizures in defined severe settings; monitoring includes respiration, reflexes and urine output. Recurrence, pulmonary oedema, HELLP features, abnormal neurology, reduced fetal movement and postpartum warning symptoms are escalation triggers. In an answer, give classification, severity, maternal-fetal assessment, emergency action, monitoring, delivery decision factors and postnatal follow-up.
Frequently Asked Questions
Can pre-eclampsia be diagnosed when urine protein is not increased?
Yes. It is a multisystem disorder. New hypertension can meet criteria with maternal organ dysfunction or uteroplacental dysfunction even without proteinuria. A normal urine result must never delay assessment of severe headache, visual symptoms, epigastric pain, breathlessness, severe blood pressure elevation, abnormal platelets, renal or liver tests, or fetal concern.
Who should receive aspirin to reduce the risk of pre-eclampsia?
Eligibility must be decided at antenatal risk assessment. Current guidelines advises 75 to 150 mg daily from 12 weeks until birth for one high-risk factor or more than one moderate-risk factor. ACOG/SMFM uses 81 mg in its jurisdiction. In India, a clinician should apply the current local protocol and assess contraindications rather than advising self-starting aspirin.
Why are fluids given cautiously in severe pre-eclampsia or eclampsia?
Capillary leak, altered kidney function and cardiac stress can make pulmonary oedema more likely. Fluids may still be required for clear indications, blood loss or resuscitation, but they need a documented intake-output plan and senior review. Routine fluid loading, including before regional analgesia in severe disease, can be harmful.
Does the danger from pre-eclampsia end once the baby is born?
No. Blood pressure and complications can appear or worsen after delivery. Severe headache, visual symptoms, upper-abdominal pain, breathlessness, chest pain, seizure, confusion or high BP postpartum require urgent assessment. Discharge planning needs a named blood-pressure check, medication review, danger-symptom advice and follow-up for persistent hypertension and future cardiovascular risk.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic